Again, administration of DZNep, which depleted EZH2 and MYC(N) (Fig. 7a–c), markedly inhibited proliferation of all the tumor cells examined, while administration of the enzymatic inhibitor GSK126 largely exhibited minimal effect (Fig. 7a–c). The gene discussed is MYC; the disease is neoplasm.